Science
Column: Paper boosting stem cell firm’s treatments is retracted – Yahoo Finance
A paper co-authored by an executive of a stem cell firm already under FDA fire has been retracted.
The markets lately are a mix of gains and volatility, and its tough, sometimes, for investors to make sense of it. In times like these, it makes sense to turn to the experts. Cathie Wood is one such expert, an investor whose stock choices have consistently outperformed the overall markets. A protégé of famed economist Arthur Laffer, market guru Wood has built her reputation on her clear view of the markets. Her firm is Ark Invest, whose Innovation ETF has over $52 billion in assets under management,…
-
Noosa News18 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
General16 hours agoCrowe toasts talkback titan for platforming ‘voiceless’
-
General12 hours agoPerth man charged after investigation into organised crime and tobacco store attacks
-
Business19 hours agoSolid superannuation gains continue to roll in
